Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Influenza Vaccines
Data on influenza vaccines published by investigators at Charite University, Research Center
March 12th, 2008
Data detailed in 'Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans' have been presented. According to recent research published in the Journal of Immunology, "Induction of T cell responses has become one of the major goals in therapeutic vaccination against viral diseases and cancer. The use of the skin as target organ for vaccine has been spurred by recent implication of epithelial dendritic cells in CD8 cell cross-priming and suggests that vaccination via the transcutaneous (TC) route may be relevant in the induction of cellular immune responses." "We have previously shown that TC application of...
Source: Vaccine Weekly (2008-03-12)
|
